Sponsored by
[ Events ]

Activity Search
Sort out
NCTS Seminar on Mathematical Biology
15:00 - 17:00, August 8, 2019 (Thursday)
Lecture Room B, 4th Floor, The 3rd General Building, NTHU
(清華大學綜合三館 4樓B演講室)
ChIP-seq Defined Genome-Wide Map of TGFb/SMAD4 Targets: Implications with Clinical Outcome of Ovarian Cancer
Michael Chan (Department of Life Science, National Chung Cheng University)


Deregulation of the transforming growth factor-b (TGFb) signaling pathway in epithelial ovarian cancer has been reported, but the precise mechanism underlying disrupted TGFb signaling in the disease remains unclear. We performed chromatin immunoprecipitation followed by sequencing (ChIP-seq) to investigate genome-wide screening of TGFb-induced SMAD4 binding in epithelial ovarian cancer. Following TGFb stimulation of the A2780 epithelial ovarian cancer cell line, we identified 2,362 SMAD4 binding loci and 318 differentially expressed SMAD4 target genes. Comprehensive examination of SMAD4-bound loci, revealed four distinct binding patterns: 1) Basal; 2) Shift; 3) Stimulated Only; 4) Unstimulated Only. TGFb stimulated SMAD4-bound loci were primarily classified as either Stimulated only (74%) or Shift (25%), indicating that TGFbstimulation alters SMAD4 binding patterns in epithelial ovarian cancer cells. Furthermore, based on gene regulatory network analysis, we determined that the TGFb-induced, SMAD4-dependent regulatory network was strikingly different in ovarian cancer compared to normal cells. Importantly, the TGFb/SMAD4 target genes identified in the A2780 epithelial ovarian cancer cell line were predictive of patient survival, based on in silico mining of publically available patient data bases. In conclusion, our data highlight the utility of next generation sequencing technology to identify genome-wide SMAD4 target genes in epithelial ovarian cancer and link aberrant TGFb/SMAD signaling to ovarian tumorigenesis. Furthermore, the identified SMAD4 binding loci, combined with gene expression profiling and in silico data mining of patient cohorts, may provide a powerful approach to determine potential gene signatures with biological and future translational research in ovarian and other cancers.


back to list  
 (C) 2019 National Center for Theoretical Sciences